Phoevos Hughes is an established pharmaceutical executive who guides clinical operations and quality management for an Indiana biosciences enterprise. His focus is on strategic planning and study design across pipeline products for clinical trials in autism spectrum disorder and necrotizing enterocolitis indications. Phoevos Hughes communicates with thought leaders across various areas of microbiome research and the therapeutic applications of drugs.
Also a consultant in his field, Mr. Hughes excels in executing trials at global levels and navigating complex regulatory hurdles. He has overseen programs through the early development to late-phase trial stages, and has knowledge of the steps required to rapidly and safely operationalize clinical developments. Mr. Hughes has also executed successful commercial launches that introduced groundbreaking drugs.
Phoevos Hughes previously served as head of medical and clinical affairs with a Raleigh, North Carolina, pharmaceutical firm. He managed medical affairs strategies across the full range of therapeutic use cases and ensured that clinical operations were ready for regulatory audits and inspections. He also oversaw team activities in operational areas such as medical information and pharmacovigilance.